Psyence Biomedical

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PBM and other ETFs, options, and stocks.

About PBM

Psyence Biomedical Ltd. is a holding company, which engages in the development and commercialization of pharmaceutical products in neurology. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. 

CEO
Jody Aufrichtig
CEOJody Aufrichtig
Employees
12
Employees12
Headquarters
Toronto, Ontario
HeadquartersToronto, Ontario
Founded
2021
Founded2021
Employees
12
Employees12

PBM Key Statistics

Market cap
8.71M
Market cap8.71M
Price-Earnings ratio
-0.10
Price-Earnings ratio-0.10
Dividend yield
Dividend yield
Average volume
15.31M
Average volume15.31M
High today
$9.85
High today$9.85
Low today
$8.06
Low today$8.06
Open price
$8.57
Open price$8.57
Volume
1.23M
Volume1.23M
52 Week high
$74.94
52 Week high$74.94
52 Week low
$1.92
52 Week low$1.92

Stock Snapshot

As of today, Psyence Biomedical(PBM) shares are valued at $9.03. The company's market cap stands at 8.71M, with a P/E ratio of -0.10.

During the trading session on 2026-04-23, Psyence Biomedical(PBM) shares reached a daily high of $9.85 and a low of $8.06. At a current price of $9.03, the stock is +12.0% higher than the low and still -8.3% under the high.

Trading volume for Psyence Biomedical(PBM) stock has reached 1.23M, versus its average volume of 15.31M.

Over the past 52 weeks, Psyence Biomedical(PBM) stock has traded between a high of $74.94 and a low of $1.92.

Over the past 52 weeks, Psyence Biomedical(PBM) stock has traded between a high of $74.94 and a low of $1.92.

PBM News

Benzinga 1d
Why Is Psyence Biomedical Stock Falling Wednesday?

Investors Pivot to Profit-Taking Trump Executive Order Boosts Sector The rally was sparked by President Donald Trump signing an executive order to accelerate me...

Why Is Psyence Biomedical Stock Falling Wednesday?
Sherwood News 2d
Psychedelic biotechs inch toward commercialization with Trump’s blessing

Biotechs working on psychedelic-based treatments have long been a staple in retail investors portfolios. Now, several are poised to gain federal approval, poten...

Psychedelic biotechs inch toward commercialization with Trump’s blessing
Benzinga 3d
PBM Jumps On Trump Psychedelic Push, Ibogaine Supply Story

Psyence Biomedical stock is charging ahead with explosive momentum. Why are PBM shares rallying? Trump Executive Order Sparks Fresh Psychedelic Sector Buying Ov...

PBM Jumps On Trump Psychedelic Push, Ibogaine Supply Story

More PBM News

TipRanks 3d
Psyence Biomedical Adds Intraday Equity Purchase Option in White Lion Financing Deal

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

TipRanks 3d
Psyence Biomedical provides update on position in global ibogaine market

Psyence Biomedical (PBM) provided an update on its strategic position in the global ibogaine market, as regulatory and clinical interest in the compound continu...

People also own

Based on the portfolios of people who own PBM. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.